155 related articles for article (PubMed ID: 17318546)
1. Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy.
Fugazzola L; Persani L; Vannucchi G; Carletto M; Mannavola D; Vigone MC; Cortinovis F; Beccaria L; Longari V; Weber G; Beck-Peccoz P
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1498-503. PubMed ID: 17318546
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement.
Fugazzola L; Persani L; Mannavola D; Reschini E; Vannucchi G; Weber G; Beck-Peccoz P
Clin Endocrinol (Oxf); 2003 Aug; 59(2):230-6. PubMed ID: 12864801
[TBL] [Abstract][Full Text] [Related]
3. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
Giusti M; Zoccola R; Guazzini B; Molinari E; Valenti S; Villa G; Bertolazzi L; Minuto F
Minerva Endocrinol; 2003 Sep; 28(3):191-203. PubMed ID: 14605601
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
[TBL] [Abstract][Full Text] [Related]
6. [123I-scintigraphy and perchlorate depletion test in the diagnosis of congenital hypothyroidism].
Meller J; Zappel H; Conrad M; Roth C; Emrich D; Becker W
Nuklearmedizin; 1998 Jan; 37(1):7-11. PubMed ID: 9467163
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of 123iodine scintigraphy and perchlorate discharge test in the diagnosis of congenital hypothyroidism.
Meller J; Zappel H; Conrad M; Roth C; Emrich D; Becker W
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():24-7. PubMed ID: 9439910
[TBL] [Abstract][Full Text] [Related]
8. Expanding use of recombinant hTSH.
Fugazzola L
Ann Endocrinol (Paris); 2007 Sep; 68(4):220-3. PubMed ID: 17689475
[TBL] [Abstract][Full Text] [Related]
9. The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism.
Schoen EJ; Clapp W; To TT; Fireman BH
Pediatrics; 2004 Dec; 114(6):e683-8. PubMed ID: 15574601
[TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.
Giovanella L; Ceriani L; Ghelfo A; Keller F; Sacchi A; Maffioli M; Spriano G
Clin Chem Lab Med; 2006; 44(5):648-52. PubMed ID: 16681439
[TBL] [Abstract][Full Text] [Related]
11. Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation.
Rabbiosi S; Vigone MC; Cortinovis F; Zamproni I; Fugazzola L; Persani L; Corbetta C; Chiumello G; Weber G
J Clin Endocrinol Metab; 2013 Apr; 98(4):1395-402. PubMed ID: 23426615
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.
Wong R; Topliss DJ; Bach LA; Hamblin PS; Kalff V; Long F; Stockigt JR
Intern Med J; 2009 Mar; 39(3):156-63. PubMed ID: 19383064
[TBL] [Abstract][Full Text] [Related]
13. The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.
Kowalska A; Pałyga I; Gąsior-Perczak D; Walczyk A; Trybek T; Słuszniak A; Mężyk R; Góźdź S
PLoS One; 2015; 10(7):e0133852. PubMed ID: 26230494
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
[TBL] [Abstract][Full Text] [Related]
15. Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients.
Chianelli M; Todino V; Graziano FM; Panunzi C; Pace D; Guglielmi R; Signore A; Papini E
Eur J Endocrinol; 2009 Mar; 160(3):431-6. PubMed ID: 19074463
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).
Meier CA; Braverman LE; Ebner SA; Veronikis I; Daniels GH; Ross DS; Deraska DJ; Davies TF; Valentine M; DeGroot LJ
J Clin Endocrinol Metab; 1994 Jan; 78(1):188-96. PubMed ID: 8288703
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.
Jarzab B; Handkiewicz-Junak D; Roskosz J; Puch Z; Wygoda Z; Kukulska A; Jurecka-Lubieniecka B; Hasse-Lazar K; Turska M; Zajusz A
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1077-86. PubMed ID: 12783219
[TBL] [Abstract][Full Text] [Related]
18. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.
Pötzi C; Moameni A; Karanikas G; Preitfellner J; Becherer A; Pirich C; Dudczak R
Clin Endocrinol (Oxf); 2006 Oct; 65(4):519-23. PubMed ID: 16984246
[TBL] [Abstract][Full Text] [Related]
19. Congenital hypothyroidism: etiology.
Dias VM; Campos AP; Chagas AJ; Silva RM
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):815-26. PubMed ID: 21073124
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine.
Robbins RJ; Driedger A; Magner J;
Thyroid; 2006 Nov; 16(11):1121-30. PubMed ID: 17123339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
